Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Sandra Horning
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Chemicals & Drugs
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
22
Hoppe, Richard
17
Negrin, Robert
15
Blume, Karl
14
Chao, Nelson
13
Long, Gwynn
12
Warnke, Roger
8
Advani, Ranjana
7
Brown, Byron
7
Johnston, Laura
7
Wong, Ruby
7
Stockerl-Goldstein, Keith
6
Hu, Wendy
4
Levy, Ronald
4
Breslin, Sheila
4
Ekstrand, Bradley
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Sandra Horning (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Weinberg Olga K; Ma Lisa; Seo Katie; Beck Andrew H; Pai Reetesh K; Morales Anjali; Kim Youn; Sundram Uma; Tan Daryl; Horning Sandra J; Hoppe Richard T; Natkunam Yasodha; Arber Daniel A
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
The American journal of surgical pathology 2009;33(4):591-8.
-
2008: Horning Sandra J
Follicular lymphoma, survival, and rituximab: is it time to declare victory?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4537-8.
-
2008: Chen Andy I; McMillan Alex; Negrin Robert S; Horning Sandra J; Laport Ginna G
Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):741-7.
-
2008: Horning Sandra J
Follow-up of adult cancer survivors: new paradigms for survivorship care planning.
Hematology/oncology clinics of North America 2008;22(2):201-10, v.
-
2007: Kuzel Timothy M; Li Shuli; Eklund John; Foss Francine; Gascoyne Randy; Abramson Neil; Schwerkoske John F; Weller Edie; Horning Sandra J
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.
Leukemia & lymphoma 2007;48(12):2397-402.
-
2007: Macdonald D A; Ding K; Gospodarowicz M K; Wells W A; Pearcey R G; Connors J M; Winter J N; Horning S J; Djurfeldt M S; Shepherd L E; Meyer R M
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1680-4.
-
2007: Advani Ranjana; Maeda Lauren; Lavori Philip; Quon Andrew; Hoppe Richard; Breslin Sheila; Rosenberg Saul A; Horning Sandra J
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3902-7.
-
2007: Ganjoo Kristen; Advani Ranjana; Mariappan M Rajan; McMillan Alex; Horning Sandra
Non-Hodgkin lymphoma of the breast.
Cancer 2007;110(1):25-30.
-
2007: Advani Ranjana; Horwitz Steven; Zelenetz Andrew; Horning Sandra J
Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine.
Leukemia & lymphoma 2007;48(3):521-5.
-
2007: de Jong Daphne; Rosenwald Andreas; Chhanabhai Mukesh; Gaulard Philippe; Klapper Wolfram; Lee Abigail; Sander Birgitta; Thorns Christoph; Campo Elias; Molina Thierry; Norton Andrew; Hagenbeek Anton; Horning Sandra; Lister Andrew; Raemaekers John; Gascoyne Randy D; Salles Gilles; Weller Edie;
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):805-12.
-
2007: Heidenreich Paul A; Schnittger Ingela; Strauss H William; Vagelos Randall H; Lee Byron K; Mariscal Carol S; Tate David J; Horning Sandra J; Hoppe Richard T; Hancock Steven L
Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):43-9.
-
2006: Law Lisa Y; Horning Sandra J; Wong Ruby M; Johnston Laura J; Laport Ginna G; Lowsky Robert; Shizuru Judith A; Blume Karl G; Negrin Robert S; Stockerl-Goldstein Keith E
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):703-11.
-
2006: Habermann Thomas M; Weller Edie A; Morrison Vicki A; Gascoyne Randy D; Cassileth Peter A; Cohn Jeffrey B; Dakhil Shaker R; Woda Bruce; Fisher Richard I; Peterson Bruce A; Horning Sandra J
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3121-7.
-
2006: Ganjoo Kristen N; An Caroline S; Robertson Michael J; Gordon Leo I; Sen Joy A; Weisenbach Jill; Li Shuli; Weller Edie A; Orazi Attilio; Horning Sandra J
Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
Leukemia & lymphoma 2006;47(6):998-1005.
-
2006: Winter Jane N; Weller Edie A; Horning Sandra J; Krajewska Maryla; Variakojis Daina; Habermann Thomas M; Fisher Richard I; Kurtin Paul J; Macon William R; Chhanabhai Mukesh; Felgar Raymond E; Hsi Eric D; Medeiros L Jeffrey; Weick James K; Reed John C; Gascoyne Randy D
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
Blood 2006;107(11):4207-13.
-
2006: Advani Ranjana; Ai Weiyun Z; Horning Sandra J
Management of advanced stage Hodgkin lymphoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(3):241-7.
-
2005: Meyer Ralph M; Gospodarowicz Mary K; Connors Joseph M; Pearcey Robert G; Bezjak Andrea; Wells Woodrow A; Burns Bruce F; Winter Jane N; Horning Sandra J; Dar A Rashid; Djurfeldt Marina S; Ding Keyue; Shepherd Lois E;
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4634-42.
-
2005: Horning Sandra J; Younes Anas; Jain Vinay; Kroll Stewart; Lucas Jennifer; Podoloff Donald; Goris Michael
Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):712-9.
-
2004: Beynet David P; Wee Sue A; Horwitz Steven S; Kohler Sabina; Horning Sandra; Hoppe Richard; Kim Youn H
Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
Archives of dermatology 2004;140(9):1140-6.
-
2004: Horning Sandra J; Weller Edie; Kim KyungMann; Earle John D; O'Connell Michael J; Habermann Thomas M; Glick John H
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3032-8.
-
2004: Horwitz Steven M; Horning Sandra J
Rituximab in stem cell transplantation for aggressive lymphoma.
Current hematology reports 2004;3(4):227-9.
-
2004: Advani Ranjana; Rosenberg Saul A; Horning Sandra J
Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1454-9.
-
2004: Horwitz Steven M; Negrin Robert S; Blume Karl G; Breslin Sheila; Stuart Monic J; Stockerl-Goldstein Keith E; Johnston Laura J; Wong Ruby M; Shizuru Judith A; Horning Sandra J
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
Blood 2004;103(3):777-83.
-
2003: Horning Sandra J
Future directions in radioimmunotherapy for B-cell lymphoma.
Seminars in oncology 2003;30(6 Suppl 17):29-34.
-
2003: Ekstrand Bradley C; Lucas Jennifer B; Horwitz Steven M; Fan Zhen; Breslin Sheila; Hoppe Richard T; Natkunam Yasodha; Bartlett Nancy L; Horning Sandra J
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Blood 2003;101(11):4285-9.
-
2002: Ekstrand Bradley C; Horning Sandra J
Lymphocyte predominant Hodgkin's disease: more patience than patients.
Cancer journal (Sudbury, Mass.) 2002;8(5):367-8.
-
2002: Ekstrand Bradley C; Horning Sandra J
Lymphocyte predominant Hodgkin's disease.
Current oncology reports 2002;4(5):424-33.
-
2002: Ekstrand Bradley C; Horning Sandra J
Hodgkin's disease.
Blood reviews 2002;16(2):111-7.
-
2002: Horning Sandra J; Hoppe Richard T; Breslin Sheila; Bartlett Nancy L; Brown B William; Rosenberg Saul A
Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):630-7.
-
2001: Horning S J; Negrin R S; Hoppe R T; Rosenberg S A; Chao N J; Long G D; Brown B W; Blume K G
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
Blood 2001;97(2):404-9.
-
2001: Stuart M J; Chao N S; Horning S J; Wong R M; Negrin R S; Johnston L J; Shizuru J A; Long G D; Blume K G; Stockerl-Goldstein K E
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):552-60.
-
2001: Cao T M; Horning S; Negrin R S; Hu W W; Johnston L J; Taylor T L; Shizuru J A; Hoppe R T; Brown B W; Blume K G; Stockerl-Goldstein K E
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(5):294-301.
-
2000: Grillo-López A J; Cheson B D; Horning S J; Peterson B A; Carter W D; Varns C L; Klippenstein D L; Shen C D
Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(4):399-408.
-
2000: Horning S J; Williams J; Bartlett N L; Bennett J M; Hoppe R T; Neuberg D; Cassileth P
Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):972-80.
-
2000: Johnston L J; Stockerl-Goldstein K E; Hu W W; Negrin R S; Hoppe R T; Blume K G; Horning S J
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(5A):555-62.
-
2000: Alvarnas J C; Negrin R S; Horning S J; Hu W W; Long G D; Schriber J R; Stockerl-Goldstein K; Tierney K; Wong R; Blume K G; Chao N J
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):352-8.
-
2000: Johnston L J; Horning S J
Autologous hematopoietic cell transplantation in Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):289-300.
-
1999: Johnston L J; Horning S J
Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1999;13(5):889-918.
-
1999: Lucas J B; Horwitz S M; Horning S J; Sayegh A
Gemcitabine is active in relapsed Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2627-8.
-
1999: Cheson B D; Horning S J; Coiffier B; Shipp M A; Fisher R I; Connors J M; Lister T A; Vose J; Grillo-López A; Hagenbeek A; Cabanillas F; Klippensten D; Hiddemann W; Castellino R; Harris N L; Armitage J O; Carter W; Hoppe R; Canellos G P
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1244.
-
1998: Horning S J
Primary refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S97-101.
-
1997: Horning S J
High-dose therapy and transplantation for low-grade lymphoma.
Hematology/oncology clinics of North America 1997;11(5):919-35.
-
1997: Yuen A R; Horning S J
Recent advances in the treatment of Hodgkin's disease.
Current opinion in hematology 1997;4(4):286-90.
-
1997: Advani R; Warnke R; Sikic B I; Horning S
Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):601-3.
-
1997: Horning S J; Hoppe R T; Mason J; Brown B W; Hancock S L; Baer D; Rosenberg S A
Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1736-44.
-
1997: Yuen A R; Rosenberg S A; Hoppe R T; Halpern J D; Horning S J
Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.
Blood 1997;89(3):814-22.
-
1997: Horning S J; Chao N J; Negrin R S; Hoppe R T; Long G D; Hu W W; Wong R M; Brown B W; Blume K G
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
Blood 1997;89(3):801-13.
-
1996: Stockerl-Goldstein K E; Horning S J; Negrin R S; Chao N J; Hu W W; Long G D; Hoppe R T; Amylon M D; Brown B W; Wong R M; Blume K G
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):76-85.
-
1996: Horning S J
Purine analogs in marginal-zone lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 6():S21-6.
-
1996: Horning S J; Rosenberg S A; Hoppe R T
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():105-8.
-
1995: Yuen A R; Kamel O W; Halpern J; Horning S J
Long-term survival after histologic transformation of low-grade follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1726-33.
-
1995: Negrin R S; Kusnierz-Glaz C R; Still B J; Schriber J R; Chao N J; Long G D; Hoyle C; Hu W W; Horning S J; Brown B W
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
Blood 1995;85(11):3334-41.
-
1995: Bartlett N L; Rosenberg S A; Hoppe R T; Hancock S L; Horning S J
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1080-8.
-
1995: Chao N J; Kastrissios H; Long G D; Negrin R S; Horning S J; Wong R M; Blaschke T F; Blume K G
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
Cancer 1995;75(6):1354-9.
-
1994: Horning S J; Negrin R S; Chao J C; Long G D; Hoppe R T; Blume K G
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2552-8.
-
1994: Bartlett N L; Rizeq M; Dorfman R F; Halpern J; Horning S J
Follicular large-cell lymphoma: intermediate or low grade?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1349-57.
-
1994: Horning S J
Treatment approaches to the low-grade lymphomas.
Blood 1994;83(4):881-4.
-
1994: Horning S J; Adhikari A; Rizk N; Hoppe R T; Olshen R A
Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):297-305.
-
1994: Horning S J
Low-grade lymphoma 1993: state of the art.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():23-7.
-
1993: Horning S J
Natural history of and therapy for the indolent non-Hodgkin's lymphomas.
Seminars in oncology 1993;20(5 Suppl 5):75-88.
-
1993: Schriber J R; Negrin R S; Chao N J; Long G D; Horning S J; Blume K G
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(10):1491-5.
-
1993: Chao N J; Berry G J; Advani R; Horning S J; Weiss L M; Blume K G
Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Transplantation 1993;55(6):1425-8.
-
1993: Bartlett N L; Kwak L W; Horning S J
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
Cancer 1993;71(12):4034-42.
-
1993: Chao N J; Schriber J R; Grimes K; Long G D; Negrin R S; Raimondi C M; Horning S J; Brown S L; Miller L; Blume K G
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.
Blood 1993;81(8):2031-5.
-
1992: Horning S J; Ang P T; Hoppe R T; Rosenberg S A
The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):747-54.
-
1992: Chao N J; Tierney D K; Bloom J R; Long G D; Barr T A; Stallbaum B A; Wong R M; Negrin R S; Horning S J; Blume K G
Dynamic assessment of quality of life after autologous bone marrow transplantation.
Blood 1992;80(3):825-30.
-
1992: Advani R; Chao N J; Horning S J; Blume K G; Ahn D K; Lamborn K R; Fleming N C; Bonnem E M; Greenberg P L
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
Annals of internal medicine 1992;116(3):183-9.
-
1991: Kwak L W; Wilson M; Weiss L M; Horning S J; Warnke R A; Dorfman R F
Clinical significance of morphologic subdivision in diffuse large cell lymphoma.
Cancer 1991;68(9):1988-93.
-
1991: Hardy R; Horning S J
Molecular biologic studies in the clinical evaluation of non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1991;5(5):891-900.
-
1991: Kwak L W; Wilson M; Weiss L M; Doggett R; Dorfman R F; Warnke R A; Horning S J
Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1426-31.
-
1991: Horning S J; Chao N J; Negrin R S; Hoppe R T; Kwak L W; Long G D; Stallbaum B; O'Connor P; Blume K G
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():47-50.
-
1991: Chao N J; Duncan S R; Long G D; Horning S J; Blume K G
Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
Annals of internal medicine 1991;114(2):145-6.
-
1990: Chao N J; Rosenberg S A; Horning S J
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.
Blood 1990;76(7):1293-8.
-
1990: Kwak L W; Halpern J; Olshen R A; Horning S J
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):963-77.
-
1990: Horning S J; Galili N; Cleary M; Sklar J
Detection of non-Hodgkin's lymphoma in the peripheral blood by analysis of antigen receptor gene rearrangements: results of a prospective study.
Blood 1990;75(5):1139-45.
-
1989: Horning S J; Carrier E K; Rouse R V; Warnke R A; Michie S A
Lymphomas presenting as histologically unclassified neoplasms: characteristics and response to treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1281-7.
-
1989: Medeiros L J; Picker L J; Gelb A B; Strickler J G; Brain S W; Weiss L M; Horning S J; Warnke R A
Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1009-17.
-
1989: Morrison W H; Hoppe R T; Weiss L M; Picozzi V J; Horning S J
Small lymphocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(5):598-606.
-
1989: Brown S L; Miller R A; Horning S J; Czerwinski D; Hart S M; McElderry R; Basham T; Warnke R A; Merigan T C; Levy R
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon.
Blood 1989;73(3):651-61.
-
1989: Medeiros L J; Weiss L M; Picker L J; Clayberger C; Horning S J; Krensky A M; Warnke R A
Expression of LFA-1 in non-Hodgkin's lymphoma.
Cancer 1989;63(2):255-9.
-
1988: Horning S J; Hoppe R T; Hancock S L; Rosenberg S A
Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1822-31.
-
1988: Strickler J G; Copenhaver C M; Rojas V A; Horning S J; Warnke R A
Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression.
American journal of clinical pathology 1988;90(3):257-61.
-
1988: Hancock S L; Hoppe R T; Horning S J; Rosenberg S A
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Annals of internal medicine 1988;109(3):183-9.
-
1988: Medeiros L J; Picker L J; Horning S J; Warnke R A
Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
Cancer 1988;61(9):1844-51.
-
1984: Horning S J; Doggett R S; Warnke R A; Dorfman R F; Cox R S; Levy R
Clinical relevance of immunologic phenotype in diffuse large cell lymphoma.
Blood 1984;63(5):1209-15.
-
1984: Doggett R S; Wood G S; Horning S; Levy R; Dorfman R F; Bindl J; Warnke R A
The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.
The American journal of pathology 1984;115(2):245-52.
-
1983: Wood G S; Burke J S; Horning S; Doggett R S; Levy R; Warnke R A
The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.
Blood 1983;62(2):464-72.
Sign-in to see more
